A neutral, research-focused comparison of two metabolic research compounds — Triple Regulator (a GLP-1/GIP/glucagon tri-agonist) and Cagrilintide (an amylin analog).
Triple Regulator is a tri-agonist studied at GLP-1, GIP, and glucagon receptors. Cagrilintide is a long-acting amylin analog. They are structurally and mechanistically distinct research compounds.
Both appear in metabolic research literature but target different receptor systems. This page is a factual overview for researchers comparing the two — not guidance on use.
For either compound, the questions are the same: independent HPLC + mass-spec testing, a lot-matched public COA, and documented origin. Both are supplied by Proven Biology as US-made, third-party-tested research peptides.